Compare ECPG & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ECPG | SBFM |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 6.0M |
| IPO Year | 1999 | N/A |
| Metric | ECPG | SBFM |
|---|---|---|
| Price | $67.56 | $1.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $77.33 | $7.00 |
| AVG Volume (30 Days) | ★ 270.7K | 31.9K |
| Earning Date | 05-06-2026 | 03-31-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 287.14 | N/A |
| EPS | ★ 10.91 | N/A |
| Revenue | ★ $1,768,802,000.00 | N/A |
| Revenue This Year | $3.63 | $10.26 |
| Revenue Next Year | $4.47 | $32.63 |
| P/E Ratio | $6.35 | ★ N/A |
| Revenue Growth | ★ 34.37 | N/A |
| 52 Week Low | $26.45 | $1.05 |
| 52 Week High | $74.58 | $3.90 |
| Indicator | ECPG | SBFM |
|---|---|---|
| Relative Strength Index (RSI) | 57.36 | 32.56 |
| Support Level | $65.01 | N/A |
| Resistance Level | $74.58 | $1.52 |
| Average True Range (ATR) | 2.67 | 0.05 |
| MACD | -0.39 | -0.00 |
| Stochastic Oscillator | 26.44 | 0.00 |
Encore Capital Group Inc is an international specialty finance company engaged in providing debt recovery solutions and other related services for consumers across a broad range of financial assets. It mainly purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals to repay their obligations and work toward financial recovery. The company also provides debt servicing and other portfolio management services to credit originators for non-performing loans in Europe. It has only one reportable segment, debt purchasing and recovery. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Europe, and other regions.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.